Al-Khadra Yasser, Baibars Motaz, Dakkak Wael, Niaz Zurain, Deshpande Radhika, Al-Bast Basma, Alraies M Chadi, Hafiz Abdul Moiz
Cardiovascular Division, Southern Illinois University School of Medicine, Springfield, IL, USA.
Collaborative Inpatient Medicine Service, Howard County General Hospital - Johns Hopkins Medicine, Columbia, MD, USA.
Int J Cardiol Heart Vasc. 2022 Jul 16;41:101087. doi: 10.1016/j.ijcha.2022.101087. eCollection 2022 Aug.
The current data regarding outcomes of transcatheter edge-to-edge mitral valve repair with the MitraClip system in the urgent setting has not been well described. Therefore, we sought to evaluate the outcomes of urgent MitraClip procedures compared with non-urgent ones.
The Nationwide Inpatient Sample database years 2011-2017 was used to identify hospitalizations for MitraClip in the urgent setting. Propensity score matching was used to compare the patients who underwent MitraClip in urgent versus non-urgent settings.
A total of 15,993 patients underwent the MitraClip procedures from 2011 to 2017. 3,929 (24.6%) were urgent and 12,064 (75.4%) were non-urgent. Patients in the urgent group were younger (75.08 vs 77.46) and more likely to be African American (p < 0.001). The urgent group had a higher burden of comorbidities such as diabetes, atrial fibrillation, renal failure and pulmonary circulatory disorders. Using multivariable logistic regression, there was no statistically significant difference in mortality between urgent and non-urgent groups (4.2% vs 1.8%, OR 0.64; 95% CI 0.41-1.00, p = 0.051). Using propensity score matching, there was no statistically significant difference in the in-hospital mortality between urgent and non-urgent groups (4.4% vs 2.8%, OR: 1.60, 95% CI: 0.71-3.63, p = 0.254). The risks of acute kidney injury and discharge to an outside facility were higher in the urgent group (p < 0.001).
No significant in-hospital mortality for patients who underwent urgent versus non-urgent MitraClip procedures. Therefore, urgent MitraClip procedure might be an acceptable option when indicated.
目前关于在紧急情况下使用MitraClip系统进行经导管二尖瓣缘对缘修复术的结果的数据尚未得到充分描述。因此,我们试图评估紧急MitraClip手术与非紧急手术的结果。
使用2011 - 2017年全国住院患者样本数据库来确定紧急情况下接受MitraClip治疗的住院病例。采用倾向评分匹配法比较在紧急和非紧急情况下接受MitraClip治疗的患者。
2011年至2017年共有15993例患者接受了MitraClip手术。其中3929例(24.6%)为紧急手术,12064例(75.4%)为非紧急手术。紧急组患者更年轻(75.08岁对77.46岁),且更有可能是非洲裔美国人(p < 0.001)。紧急组的合并症负担更高,如糖尿病、心房颤动、肾衰竭和肺循环障碍。使用多变量逻辑回归分析,紧急组和非紧急组之间的死亡率无统计学显著差异(4.2%对1.8%,OR 0.64;95% CI 0.41 - 1.00,p = 0.051)。采用倾向评分匹配法,紧急组和非紧急组的院内死亡率无统计学显著差异(4.4%对2.8%,OR:1.60,95% CI:0.71 - 3.63,p = 0.254)。紧急组急性肾损伤和转至外部机构的风险更高(p < 0.001)。
接受紧急与非紧急MitraClip手术的患者院内死亡率无显著差异。因此,在有指征时,紧急MitraClip手术可能是一个可接受的选择。